Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
consortium SynThera funded by the Carl Zeiss Foundation (www.synthera.eu/ ). We are seeking an excellent and enthusiastic post-doctoral researcher with a strong interest in computational microbiome research
-
Area of research: Scientific / postdoctoral posts Job description: GFZ is Germany's national centre for solid Earth research. We advance the understanding of dynamic processes to address global
-
Area of research: Scientific / postdoctoral posts Job description: GFZ is Germany's national centre for solid Earth research. We advance the understanding of dynamic processes to address global
-
and is an equal opportunity employer. Interested applicants should send their CVs and the names and addresses of 3 references to: Stanislav Zakharenko, M.D., Ph.D. Department of Developmental
-
record of scientific productivity. Previous experience in metabolomics, computational biology, and/or hematology-oncology is strongly preferred. Interested individuals should send a CV, a short summary of
-
Contract type : Fixed-term contract Level of qualifications required : PhD or equivalent Fonction : Post-Doctoral Research Visit About the research centre or Inria department The Inria centre
-
A postdoc position in the Torben Heick Jensen lab, Aarhus University, Denmark: Mammalian Nuclear ...
-mail thj@mbg.au.dk . Deadline Applications must be received no later than 15 August 2025. Application procedure Shortlisting is used. This means that after the deadline for applications – and with
-
submitted your application, you must send this person’s details (name, job title, place of work, and email address) as well as the name of the position you have applied for to: HR.Nattech@au.dk Formalities
-
, teamwork, and scientific rigor. If you’re excited about decoding immune cell regulation through innovative experimental approaches, we’d love to hear from you! To apply, please send your CV, a brief
-
-mail to DSUIscience@miami.edu . Specific research areas include: Metabolic and genetic changes required for hormone therapy resistance in prostate and breast cancers Discovery of entirely new mechanisms